Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Vycor Medical, Inc. (OTC: VYCO).

Full DD Report for VYCO

You must become a subscriber to view this report.


Recent News from (OTC: VYCO)

Vycor Medical Reports Financial Results for the Year Ended December 31st, 2017
BOCA RATON, FL / ACCESSWIRE / March 30, 2018 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2017. Vycor's revenues for the year ended December 31, 2017 were $1...
Source: ACCESSWIRE
Date: March, 30 2018 09:00
Vycor Announces That it is Accelerating the Roll-out of its Enhanced VBAS due to Surgeon Feedback
BOCA RATON, Florida , March 6, 2018 /PRNewswire/ -- Vycor Medical, Inc. (OTCQB: VYCO) had previously announced in October 2017 to its customer base the release of its enhanced VBAS, which it would be slowly rolling out over the course of this year as it ran down its inventory of the c...
Source: PR Newswire
Date: March, 06 2018 08:30
Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2017
BOCA RATON, FL / ACCESSWIRE / November 13, 2017 / Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the three and nine months ended September 30, 2017. Vycor's revenues for the nine months e...
Source: ACCESSWIRE
Date: November, 13 2017 08:30
Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2017
Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2017
Source: OTC Markets
Date: November, 13 2017 00:00
Vycor Medical Reports Financial Results for the Three and Six Months Ended June 30th, 2017
BOCA RATON, FL / ACCESSWIRE / August 11, 2017 / Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the three and six months ended June 30, 2017. Vycor's revenues for the six months ended June 3...
Source: ACCESSWIRE
Date: August, 11 2017 09:00
Vycor Medical Reports Financial Results for the Three and Six Months Ended June 30th, 2017
Vycor Medical Reports Financial Results for the Three and Six Months Ended June 30th, 2017
Source: OTC Markets
Date: August, 11 2017 00:00
Vycor Medical Reports Financial Results for the Period Ended March 31st, 2017
BOCA RATON, FL / ACCESSWIRE / May 11, 2017 / Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the period ended March 31, 2017. Vycor's revenues for the period ended March 31, 2017 were $42...
Source: ACCESSWIRE
Date: May, 11 2017 09:01
Vycor Medical Reports Financial Results for the Year Ended December 31st, 2016
BOCA RATON, FL / ACCESSWIRE / March 31, 2017 / Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2016. Vycor's revenues for the year ended December 31, 2016 were...
Source: ACCESSWIRE
Date: March, 31 2017 09:00
Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2016
BOCA RATON, FL / ACCESSWIRE / November 14, 2016 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the three and nine months ended September 30, 2016. Vycor's revenues for the quarter were $...
Source: ACCESSWIRE
Date: November, 14 2016 08:32
New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency
BOCA RATON, Florida , September 28, 2016 /PRNewswire/ -- Vycor Medical, Inc. ("Vycor") (OTCQB-VYCO) reports that a new peer-reviewed study published in "BioMed Research International" shows improvements in visual search following the use of NovaVision's NeuroEyeCoach. The three-cent...
Source: PR Newswire
Date: September, 28 2016 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-15N/A0.2899N/AN/A0
2018-08-14N/A0.2899N/AN/A0
2018-08-13N/A0.2899N/AN/A0
2018-08-10N/A0.2899N/AN/A0
2018-08-09N/A0.2899N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-273,5003,500100.0000Short
2018-07-25500500100.0000Short
2018-07-231,0003,00033.3333Cover
2018-07-1711,00021,30251.6383Short
2018-06-263,5007,40047.2973Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VYCO.


About Vycor Medical, Inc. (OTC: VYCO)

Logo for Vycor Medical, Inc. (OTC: VYCO)

Vycor is dedicated to providing the medical community with innovative and superior neurosurgical and neurotherapeutic solutions and operates two distinct business units within the medical industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision develops non invasive, computer based light stimulation therapies for those suffering from vision loss resulting from neurological trauma

 

Contact Information

 

 

Current Management

  • Adrian Christopher Liddell / CFO, IR
  • Peter C. Zachariou / CEO, Vice President
  • David Marc Cantor / President
  • Adrian Christopher Liddell / Chairman
  • Oscar Bronsther / Audit Committee Member
  • David Marc Cantor /
  • Steven Girgenti / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Lowell M. Rush / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
    • Lowell Rush joined Paybox Corp, as acting Chief Financial Officer in October , and was appointed its Chief Financial Officer, Secretary and Treasurer in December . Prior to joining the Company, Mr. Rush held positions as Chief Operating Officer of Cosmetic Dermatology, Inc. from to , Vice President / Chief Financial Officer of Bijoux Terner from to , and Chief Financial Officer of Little Switzerland, Inc. from to , in addition to various financial management roles at Sunglass Hut International, Burger King Corp. and KnightRidder. He began his career with Big firms Ernst amp Young and Deloitte amp Touche. Mr. Rush is a Certified Public Accountant with a Bachelor of Science degree in Accounting from the State University of New York at Buffalo, and holds an Executive Masters of Business Administration degree in International Business from the University of Miami. Mr. Rush has years of experience, primarily in financial management and operational development. He is experienced in strategic planning and implementation, SEC compliance and reporting, cost reduction and avoidance, and corporate development. He plays a key role in leading Direct Insite s financial organization as the company continues to execute upon its growth strategy and to explore new strategic opportunities.
  • Peter C. Zachariou /

Current Share Structure

  • Market Cap: $9,860,591 - 03/09/2018
  • Authorized: 1,500,000,000 - 03/09/2018
  • Issue and Outstanding: 20,123,655 - 03/09/2018
  • Float: 8,339,520 - 04/07/2016

 


Recent Filings from (OTC: VYCO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 24 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 30 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 30 2018
All other definitive information statements
Filing Type: DEF 14CFiling Source: edgar
Filing Date: March, 13 2018
Information statements. Revised preliminary material
Filing Type: PRER14CFiling Source: edgar
Filing Date: March, 01 2018
Preliminary proxy statement containing all other information
Filing Type: PRE 14CFiling Source: edgar
Filing Date: February, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 13 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: September, 15 2017

 

 


Daily Technical Chart for (OTC: VYCO)

Daily Technical Chart for (OTC: VYCO)


Stay tuned for daily updates and more on (OTC: VYCO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VYCO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VYCO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of VYCO and does not buy, sell, or trade any shares of VYCO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/